aPKCι promotes gallbladder cancer tumorigenesis and gemcitabine resistance by competing with Nrf2 for binding to Keap1

Gallbladder cancer (GBC) is a highly malignant bile duct cancer with poor prognosis characterized by its insensitivity to chemotherapy. Emerging evidence indicates that cytoprotective antioxidation is involved in drug resistance of various cancers; however, the underlying molecular mechanisms remain...

Descripción completa

Detalles Bibliográficos
Autores principales: Tian, Li, Lu, Yun, Yang, Tao, Deng, Zhengdong, Xu, Lei, Yao, Wei, Ma, Chaoqun, Li, Xiangyu, Zhang, Jian, Liu, Yan, Wang, Jianming
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2019
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6395946/
https://www.ncbi.nlm.nih.gov/pubmed/30822690
http://dx.doi.org/10.1016/j.redox.2019.101149

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6395946/
https://www.ncbi.nlm.nih.gov/pubmed/30822690
http://dx.doi.org/10.1016/j.redox.2019.101149

Ejemplares similares